Back to Market Feed

DUPIXENT 200 MG/1.14 ML PEN

Dupilumab
$1772.9900per ML

Strength

200 mg/1.14mL

NDC

00024591902

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

DUPILUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761055

On Market Since

6/14/2021

Pharmacological Classes

Antibodies
Monoclonal
Interleukin 4 Receptor alpha Antagonists
Interleukin-4 Receptor alpha Antagonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+5.0%

3Y

N/A

5Y

N/A

All

+10.7%

Generic Alternatives

1 alternative • Same active ingredient

DUPIXENT 200 MG/1.14 ML SYRING
Brand
00024591801•Sanofi-Aventis U.S. LLC
$1774.7544
+0% more

Related Drugs

Same classification

PRALUENT 75 MG/ML PEN
Brand
61755002002•Regeneron Pharmaceuticals, Inc.
$258.0650
per ML
PRALUENT 150 MG/ML PEN
Brand
61755002102•Regeneron Pharmaceuticals, Inc.
$258.1639
per ML
REPATHA 140 MG/ML SYRINGE
Brand
72511050101•Amgen Inc.
$281.2448
per ML
REPATHA 140 MG/ML SYRINGE
Brand
72511075001•Amgen Inc.
$281.2448
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511039302•Amgen Inc.
$281.9492
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511076002•Amgen Inc.
$281.9492
per ML